Abstract
Introduction
The term nephrocalcinosis (NC) is commonly used to describe renal parenchymal calcifications. NC was originally defined by Albright in 1934 as diffuse renal calcifications in patients with primary hyperparathyroidism (HPT) 1 (Table 1 ). The primary objective of this study was to contrast the frequency and extent of nephrocalcinosis in these three groups of calcium stone formers who were carefully studied endoscopically to distinguish between stones and tissue deposits. The uniquely different patients with medullary sponge kidney are not addressed here 11 .
Materials and Methods
Patients who underwent percutaneous nephrolithotomy (PNL) for calcium urolithiasis who underwent digital video mapping, as well as biopsy of the renal cortex and papilla as part of our NIH supported stone pathogenesis project, were entered in this study (NIDDK#P01DK56788). The clinical and histopathologic findings in this cohort of patients is the subject of another report 9 . The study was approved by the Indiana University Institutional Review Board (#1010002261).
The IPSF were separated into two groups, HASF and BRSF. A cut point of 50% HA as an average of all analyzed stone material was utilized to distinguish between HASF and ICSF. All calculi were analyzed by micro-CT, a non-destructive technique followed by Flexible ureteroscopes are also used when there is a difficult to locate calyx or when the infundibulum to a given calyx is not accommodating. In addition, if a calcification is visible on fluoroscopy but not able to be identified endoscopically, a puncture is performed down on to the calcification utilizing an 18-gauge needle and a zip or glidewire is passed into the more central renal collecting system. The wire is then pulled out through and through and is followed to lead to the occult calyx of interest. When this so called non-dilated puncture technique is utilized, a skin incision is not required, no CT scan who did not undergo a second look nephroscopy were excluded as we were unable to determine if the residual calcifications were stones or NC.
All CT scans were done at Methodist Hospital and were interpreted by a single radiologist (TH) who was blinded to the endoscopic findings.
All analyses were performed using SPSS Statistical Software, release 19.0 (SPSS Inc., Chicago, IL, USA). In all tests, a two-tailed significance level of 0.05 was used.
Results
We had a total of 54 patients (11 HASF, 15 BRSF, and 28 ICSF) and 67 renal units (14 HASF, 19 BRSF, and 34 ICSF). Urinary calcium excretion and calcium phosphate supersaturation were significantly higher in those patients exhibiting NC (Table 4 ). There was no correlation with the percent HA or BR and the presence of NC.
Discussion
As evidenced by the original definition proposed by Dr. Albright, NC has become highly associated with the etiologies of primary HPT, dRTA, and medullary sponge kidney. NC is not thought to be common in stone formers without systemic disease.
However, no one has ever looked at the incidence/prevalence of NC in a cohort of patients with calcium nephrolithiasis who do not have systemic disease. The main reason for this is that in the past we did not have the ability to make the distinction between NC and nephrolithiasis. With the dramatic improvements in endourologic technology, we are now able to distinguish between these two entities.
The radiologist is usually one of the first to suggest the presence of NC.
However, studies have shown that the radiologist's ability to detect NC is often not accurate 12, 13 . The most sensitive radiological tool to detect NC is computed tomography and standard x-rays are used to follow the course of NC 14 . Although ultrasound is the modality of choice for assessing pediatric NC it is rarely used in the adult population because it is subjective and lacks specificity 13, 14 . The diagnosis of NC can be suggested on ultrasound, abdominal x-ray and computed tomography however none possesses diagnostic capacity to distinguish between NC and stone 4 . Additionally, it is our experience that even when the radiologist suggests a diagnosis of NC, on numerous occasions we have found stones to be present on endoscopic evaluation and treatment 15 .
In the past, all calcium stone formers have been considered as a single group.
However, our previous work has demonstrated that a significant difference exists between CaP stone formers and ICSF. Moreover, there is also a distinct difference between HASF and BRSF. This paper further substantiates the underlying difference between these three calcium stone forming groups.
Our main finding is that NC is common even in the absence of systemic disease.
More specifically, in calcium stone forming patients who do not have primary HPT, dRTA or MSKD, a significant number of these patients will have NC. Previously, absent these conditions, NC has not been thought to be a common occurrence, however, there are no formal studies addressing the issue. The data presented herein are the first to document the incidence/prevalence of NC in patients with calcium urolithiasis who do not have systemic disease or MSKD and has been made possible by the dramatic advances in endourologic technology and techniques of the current era of nephrolithiasis surgery.
Our observation that NC can occur and indeed is common in the absence of systemic disease is noteworthy given the increasing incidence of HASF and BRSF 16, 17 .
Viewed from another perspective, based on these data, the majority of patients with predominantly calcium phosphate stone may be expected to have concomitant NC in the absence of systemic disease. The implications of our findings are important emphasizing the advantages of endourologic approaches such as PCNL and URS over ESWL which cannot discriminate NL from NC.
The characteristics of NC in ICSF patients differs significantly from HASF and BRSF both in the frequency and amount of NC present as would be expected given our understanding of the pathophysiology of ICSF. While it is possible that the NC found in ICSF could be explained by stones which were overlooked during the secondary PCNL, we think this is unlikely given the extensive use of multiple flexible instruments and nondilated punctures during the procedures. The amount of NC when present in ICSF was dramatically less than observed in the HASF and BRSF.
In concordance with our earlier work, the presence of NC is another factor that can be used to distinguish the three calcium forming groups: HASF, BRSF, and ICSF.
As we have demonstrated here, NC is prevalent in the majority of HASF and BRSF patients but rare in the ICSF group. These findings are entirely consistent with the differing pathways for stone formation for CaP and CaOx stones: intra-tubular deposits are greater in the HASF and BRSF groups and non-existent in the ICSF group.
Additionally, urinary pH, supersaturation of CaP, and calcium excretion were significantly greater in the HASF and BRSF groups compared to the ICSF groups in this cohort of patients 9 .
Conclusion
The only accurate method to distinguish between NC and nephrolithiasis is endoscopically. Using endoscopic techniques, we have demonstrated that patients without systemic disease who form HA and BR stones commonly have coexistent NC.
NC can occur in ICSF, as well. However, the quantity and frequency of NC in this group of patients is dramatically less than in patients who form calcium phosphate stones.
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FIGURE LEGENDS:
Figure 1A: A papillae from an ICSF patient showing a small amount of Randall's plaque (arrows). The papillae is otherwise normal appearing. Figure 1B : A papillae from a BRSF patient. The papillae is severely diseased. It is flattened. In the center of the papillae is a grossly dilated Bellini duct (asterisk). In addition to Randall's plaque (arrows), Bellini duct deposits are seen (arrowheads). 
